Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1994-07-06
1998-10-20
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242041, 530350, 530395, A61K 39245, A61K 3912, C07K 100, C07K 1400
Patent
active
058243194
ABSTRACT:
The present invention relates to the construction of a recombinant plasmid which is capable of expressing a secretory truncated glycoprotein (Tgp) of Varicella-zoster virus (VZV) in mammalian cells. The secretory Tgp of the present invention contains at least one epitope capable of inducing antibody response. The present invention contemplates the production and utilization of this secretory Tgp in a vaccine against chickenpox and/or shingles. The present invention is also directed towards the use of the secretory Tgp in diagnostic assays for detection of VZV. The present invention is also directed to first antibodies specific to secretory Tgp and to second antibodies specific to the first antibodies. These second antibodies are also useful in diagnostic assays for VZV.
REFERENCES:
patent: 4008317 (1977-02-01), Gits
patent: 4016043 (1977-04-01), Schuurs et al.
patent: 4347311 (1982-08-01), Schmitz
patent: 4663277 (1987-05-01), Wang
patent: 4686101 (1987-08-01), Ellis et al.
patent: 4769239 (1988-09-01), Ellis et al.
Adams et al. (1989) "Restriction Fragment Differences Between the Genomes of the Oka Varicella Vaccine Virus and American Wild-Type Varicella-Zoster Virus", J. Med. Virol. 29, 38-45.
Cabirac et al. (1988) "Expression of Varicella-Zoster Virus Glycoprotein I in Cells Infected with a Vaccina Virus Recombinant", Virus Research 10, 205-214.
Claesson-Welsh et al. (1987) "Amino-Terminal Sequence, Synthesis, and Membrane Insertion of Glycoprotein B of Herpes Simplex Virus Type 1", J. Virol 61, 1-7.
Davison et al. (1986) "The complete DNA Sequence of Varicella-Zoster Virus", J. Gen Virol. 67, 1759-1816.
Davison et al. (1986) "New Common Nomenclature for Glycoprotein Genes of Varicella-Zoster Virus and Their Glycosylated Products", J. Virol. 57, 1195-1197.
Diaz et al. (1988) "Immunity to Whole Varicella-Zoster Virus Antigen and Glycoproteins I and p170: Relation to the Immunizing Regimen of Live Attenuated Varicella Vaccine", J. Infect. Dis. 158, 1245-1252.
Englund et al. (1989)) "Placebo-Controlled Trial of Varicella Vaccine Given With or After Measles-Mumps-Rubella Vaccine", J. Pediatr. 114, 37-44.
Hobman et al. (1988) "Translocation of Rubella Virus Glycoportein E1 into the Endoplasmic Reticulum", J. Virol. 62, 4259-4264.
Hope et al. (1985) "GCN4 Protein, Synthesized In Vitro, Binds HIS 3 Regulatory Sequences: Implications for General Control of Amino Acid Biosynthetic Genes in Yeast", Cell 43, 177-186.
Kato et al. (1989) "Transcription Mapping of Glycoprotein I (gpI) and gpIV of Varicella-Zoster Virus and Immunological Analysis of the gpI Produced in Cells Infected with the Recombinant Vaccinia Virus", Microbiol. Immunol. 33, 299-312.
Litwin et al. (1990) "Cell Surface Expression of the Varicella-Zoster Virus Glycoproteins and Fc Receptor", Virology 178, 263-272.
Makikado et al. (1990) "Recombinant Preparation of Glycoprotein gpII of Varicella-Zoster Virus (VZV) in Eukaryotes and Its Use", Chemical Abstracts 112, 497, Abstract No. 215209s.
Straus et al. (1988) "Varicella-Zoster Virus Infections", Ann. Intern. Med. 108, 221-237.
Vafai et al. (1984) "Analysis of Three Late Varicella-Zoster Virus Proteins, A 125,000-Molecular-Weight Protein and gp1 and gp3", J. Virol. 52, 953-959.
Vafai et al. (1987) "Induction of Antibody Against In Vitro Translation Products Encoded by Varicella-Zoster Virus Glycoprotein Genes", Virus Research 7, 325-327.
Vafai et al. (1988) "Recognition of Similar Epitopes on Varicella-Zoster Virus gpI and gpIV by Monoclonal Antibodies", J. Virol. 62, 2544-2551.
Vfai et al. (1989) "Existence of Similar Antigenic-Sites on Varicella-Zoster Virus gpI and gpIV", Virus Research 13, 319-336.
PCT International Application Number PCT/US85/00587, International Publication Number WO/85/04587, published Oct. 24, 1985.
Research Corporation Technologies Inc.
Smith Lynette F.
LandOfFree
Varicella-zoster virus antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Varicella-zoster virus antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Varicella-zoster virus antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-241817